课题基金 / 基金详情

Novel Functions of the Ah Receptor

Novel Functions of the Ah Receptor
Ah 受体的新功能
批准号:
6856536
负责人:
JOHN J REINERS
金额:
$29.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-02-01 至 2007-02-28

项目摘要

项目成果

JOHN J REINERS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. The biological functions of the aryl hydrocarbon receptor (AhR) are normallyattributed to its functioning as a ligand-activated transcription factor. However, recent studies suggest that the AhR may have ligand- independent functions. Studies with murine hepatoma cells engineered to have different AhR contents show a direct correlation between AhR content and susceptibility to apoptosis induced by ceramide, but not other agents. Recent studies have shown that ceramide causes lysosome disruption, cleavage of cytosolic Bid, release of cytochrome c, and activation of the 'mitochondria!'apoptotic pathway in AhR-containing cells. The effects of ceramide could be duplicated by the targeted disruption of lysosomes with photodynamic therapy (PDT). Because PDT and ceramide disrupt the lysosomes of AhR-deficient cells, but do not cause Bid cleavage we hypothesize that 1) lysosome disruption triggers the 'mitochondria!' apoptotic pathway via lysosomal protease cleavage of Bid, and 2) the AhR modulates processes involved in Bid cleavage. In this application we propose to use Bid null and AhR null cells to determine if activation of the 'mitochondria!' apoptotic pathway by ceramide/PDTis dependent upon 1) Bid and 2) AhR content, respectively. 3) We will determine if the inability of our AhR-deficient cell lines to cleave Bid reflects the absence of a lysosomal Bid cleavage activity, or the presence of cytosolic protein(s) that inhibit this activity. 4) We will attempt to identify the lysosomal activity responsible for Bid cleavage by conventional purification techniques, selective pharmacological inhibition, or a proteomic approach. 5) Transfection of mutated forms of the AhR into AhR-deficient cells will be used to determine the regions/functions (e.g., DNA and ligand-binding, heterodimerization, transactivation, etc.) of the AhR important in the modulation of Bid cleavage/ceramide- induced apoptosis. Lastly, 6) a series of 'oxidative stressors' will be tested to determine if oxidant-induced activation of the 'mitochondria!' apoptotic pathway is a downstream consequence of lysosome disruption and Bid cleavage. These studies will provide a mechanism linking lysosome disruption and apoptosis, and characterize a novel AhR function. The concept that lysosome disruption can trigger apoptosis, in addition to necrosis, is relevant to the mechanism of action of many toxicants, and health-related areas such as neuro and pulmonary toxicology, chemo-and phototherapy, stroke research, and reperfusion induced injury. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Potentiation of photodynamic therapy by ursodeoxycholic acid.
熊去氧胆酸增强光动力疗法。
DOI: --
发表时间: 2000
期刊: Cancer research.
影响因子: --
作者: [Kessel,D, Caruso,JA, ReinersJr,JJ]
通讯作者: ReinersJr,JJ
DOI: 10.1016/j.freeradbiomed.2010.11.006
发表时间: 2011-01-15
期刊: FREE RADICAL BIOLOGY AND MEDICINE
影响因子: 7.4
作者: [Reiners, John J., Jr., Kleinman, Miriam, Kessel, David, Mathieu, Patricia A., Caruso, Joseph A.]
通讯作者: Caruso, Joseph A.
CORE--Cell Signaling Research Core
  • 批准号:
    6750894
  • 项目类别:
  • 资助金额:
    $4.11万
  • 财政年份:
    2004
  • 负责人:
    JOHN J REINERS
  • 依托单位:
Training Program in Molecular and Cellular Toxicology
  • 批准号:
    6766910
  • 项目类别:
  • 资助金额:
    $6.41万
  • 财政年份:
    2003
  • 负责人:
    JOHN J REINERS
  • 依托单位:
Training Program in Molecular and Cellular Toxicology
  • 批准号:
    6593640
  • 项目类别:
  • 资助金额:
    $6.13万
  • 财政年份:
    2003
  • 负责人:
    JOHN J REINERS
  • 依托单位:
Training Program in Molecular and Cellular Toxicology
  • 批准号:
    7256244
  • 项目类别:
  • 资助金额:
    $5.91万
  • 财政年份:
    2003
  • 负责人:
    JOHN J REINERS
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: